We aim to enable open science by sharing meaningful data, analytical code, and results while balancing participant privacy, regulations, and data security.
GP2 has partnered with Accelerating Medicines Partnership: Parkinson’s Disease (AMP-PD), a PD genetics research platform, to distribute GP2 cohort data. GP2 data can be accessed and analyzed via AMP-PD.
You can visit GP2 GitHub to learn more. For additional genomics and machine learning tools, visit GenoML.